The aim of this study was to identify the levels of physical activity and sedentary behaviour of children and adolescents with sickle cell disease (SCA) compared to healthy individuals. A cross-sectional study with a quantitative approach was performed at a reference center for the treatment of patients with hemoglobinopathies in northeastern Brazil. Patients were recruited between October 2015 and January 2017. Eligible participants answered a Physical Activity Questionnaire for Older Children and Adolescents (PAQ-C) and were instructed to use an ActiGraph wGT3X-BT triaxial accelerometer for seven consecutive days. Fifty patients (and their 50 controls matched for age and sex) were then evaluated. We observed lower moderate (19.2 ± 11.9 and 27.1 ± 13.8 min/d; p<0.01) and vigorous PA (3.6 ± 4.1 and 7.8 ± 7.4 min/d; p<0.01) in cases than controls, respectively. There was also a significant difference among cases and controls in the following variables: total of steps (51010 ± 19600 and 59105 ± 22650; p = 0.04) and “total caloric expenditure” (1015 ± 516 and 2404 ± 1308; p<0.01), with the lowest values for the patients with SCA for all variables. Children and adolescents with SCA presented lower levels of physical activity than healthy children and adolescents, either when evaluated by PAQs or by accelerometer.
BackgroundTo establish determinants of maximum walking distance in the 6-minute walk test of children and adolescents with sickle cell anemia, and to compare the performance in this test with physical activity level between patients and healthy controls.MethodsA cross-sectional study was performed in which the participants answered the Physical Activity Questionnaire for Older Children and Adolescents, and completed the 6-minute walk test.Main resultsFifty-seven patients and 58 controls were studied. By univariate analysis of the patients, age (p < 0.0001) and indirect bilirubin (p = 0.008) were associated with maximum walking distance in the 6-minute walk test. In multivariate analysis, age was positively associated (p < 0.0001; beta: 0.75), while body mass index was inversely associated with distance walked (p = 0.047; beta: −0.32). This yields the following equation: maximum distance walked = 487.7 (age × 18.3) − (12 × body mass index) meters. Patients reported a lower physical activity level however there was no significant difference in the distance walked in six minutes between patients (500.6 ± 88.7 m) and controls (536.3 ± 94 m).ConclusionThe determinants for the 6-minute walk test in children and adolescents with sickle cell anemia were age and body mass index. There was no significant difference in the 6-minute walk test but patients with sickle cell anemia had a lower physical activity level compared to healthy controls.
32The aim of this study was to identify the levels of physical activity and sedentary 33 behaviour of children and adolescents with sickle cell disease (SCA) compared 34 to healthy individuals. A cross-sectional study with a quantitative approach was 35 performed at a reference center for the treatment of patients with 36 hemoglobinopathies in northeastern Brazil. Patients were recruited between 37 October 2015 and January 2017. Eligible participants answered a Physical 38 Activity Questionnaire for Older Children and Adolescents (PAQ-C) and were 39 instructed to use an ActiGraph wGT3X-BT triaxial accelerometer for seven 40 consecutive days. The analysis of the results was performed using the SPSS 41 software (version 13.0). Differences between means were analysed using the 42 Mann-Whitney U test and the chi-square test was used to evaluate the 43 proportions of occurrence of categorical variables, comparing patient and 44 controls groups. Among the 352 patients in the follow-up, 64 met the inclusion 45 criteria and agreed to participate. Of those, 14 did not use the accelerometer 46 during the 7 consecutive days and were excluded. 50 patients (and their 50 47 controls) were then evaluated. We observed a statistically significant difference 48 between cases and controls in the variables "total time of moderate and vigorous 49 physical activity" (p=0.009 and p=0.0001, respectively) and "daily mean of 50 moderate and vigorous physical activity" (p=0.005 and p=0.003). There was also 51 a significant difference among cases and controls in the following variables: 52 "metabolic equivalent" (MET), with p=0.04, total of steps (p=0.04) and "total 53 caloric expenditure" (p=0.0001), with the worst performances for the group of 54 patients with SCA. Children and adolescents with SCA presented lower levels of 55 physical activity than healthy children and adolescents, both when evaluated by 3 56 the PAQs or by the accelerometer. The results suggest the need to develop 57 specific programs aimed at promoting physical activity levels and reducing 58 sedentary behaviour among young individuals with SCA. 59 Sickle cell anemia is a hereditary and hematological disease that occurs due to 63 the abnormal production of red blood cells. On the other hand, childhood physical 64 activity has beneficial effects on health, both in the short and long terms, and may 65 reduce risk factors for chronic diseases. The aim of this study was to identify the 66 levels of physical activity and sedentary behaviour of children and adolescents 67 with sickle cell disease compared to healthy individuals. Participants answered a 68 Physical Activity Questionnaire for Older Children and Adolescents (PAQ-C) and 69 were instructed to use an ActiGraph wGT3X-BT triaxial accelerometer for seven 70 consecutive days. We observed children and adolescents with sickle cell anemia 71 presented lower levels of physical activity than healthy children and adolescents, 72 both when evaluated by the PAQs or by the accelerometer. The results suggest 73 the nee...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.